Characteristics and Outcomes of Hospitalized Pregnant Women With Influenza, 2010 to 2019 : A Repeated Cross-Sectional Study.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
Feb 2022
Historique:
pubmed: 28 12 2021
medline: 15 4 2022
entrez: 27 12 2021
Statut: ppublish

Résumé

Pregnant women may be at increased risk for severe influenza-associated outcomes. To describe characteristics and outcomes of hospitalized pregnant women with influenza. Repeated cross-sectional study. The population-based U.S. Influenza Hospitalization Surveillance Network during the 2010-2011 through 2018-2019 influenza seasons. Pregnant women (aged 15 to 44 years) hospitalized with laboratory-confirmed influenza identified through provider-initiated or facility-based testing practices. Clinical characteristics, interventions, and in-hospital maternal and fetal outcomes were obtained through medical chart abstraction. Multivariable logistic regression was used to evaluate the association between influenza A subtype and severe maternal influenza-associated outcomes, including intensive care unit (ICU) admission, mechanical ventilation, extracorporeal membrane oxygenation, or in-hospital death. Of 9652 women aged 15 to 44 years and hospitalized with influenza, 2690 (27.9%) were pregnant. Among the 2690 pregnant women, the median age was 28 years, 62% were in their third trimester, and 42% had at least 1 underlying condition. Overall, 32% were vaccinated against influenza and 88% received antiviral treatment. Five percent required ICU admission, 2% required mechanical ventilation, and 0.3% ( Maternal and fetal outcomes that occurred after hospital discharge were not captured. Over 9 influenza seasons, one third of reproductive-aged women hospitalized with influenza were pregnant. Influenza A H1N1 was associated with more severe maternal outcomes. Pregnant women remain a high-priority target group for vaccination. Centers for Disease Control and Prevention.

Sections du résumé

BACKGROUND BACKGROUND
Pregnant women may be at increased risk for severe influenza-associated outcomes.
OBJECTIVE OBJECTIVE
To describe characteristics and outcomes of hospitalized pregnant women with influenza.
DESIGN METHODS
Repeated cross-sectional study.
SETTING METHODS
The population-based U.S. Influenza Hospitalization Surveillance Network during the 2010-2011 through 2018-2019 influenza seasons.
PATIENTS METHODS
Pregnant women (aged 15 to 44 years) hospitalized with laboratory-confirmed influenza identified through provider-initiated or facility-based testing practices.
MEASUREMENTS METHODS
Clinical characteristics, interventions, and in-hospital maternal and fetal outcomes were obtained through medical chart abstraction. Multivariable logistic regression was used to evaluate the association between influenza A subtype and severe maternal influenza-associated outcomes, including intensive care unit (ICU) admission, mechanical ventilation, extracorporeal membrane oxygenation, or in-hospital death.
RESULTS RESULTS
Of 9652 women aged 15 to 44 years and hospitalized with influenza, 2690 (27.9%) were pregnant. Among the 2690 pregnant women, the median age was 28 years, 62% were in their third trimester, and 42% had at least 1 underlying condition. Overall, 32% were vaccinated against influenza and 88% received antiviral treatment. Five percent required ICU admission, 2% required mechanical ventilation, and 0.3% (
LIMITATION CONCLUSIONS
Maternal and fetal outcomes that occurred after hospital discharge were not captured.
CONCLUSION CONCLUSIONS
Over 9 influenza seasons, one third of reproductive-aged women hospitalized with influenza were pregnant. Influenza A H1N1 was associated with more severe maternal outcomes. Pregnant women remain a high-priority target group for vaccination.
PRIMARY FUNDING SOURCE BACKGROUND
Centers for Disease Control and Prevention.

Identifiants

pubmed: 34958603
doi: 10.7326/M21-3668
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

149-158

Commentaires et corrections

Type : CommentIn

Auteurs

Rachel Holstein (R)

Centers for Disease Control and Prevention, Atlanta, Georgia (R.H., F.S.D., A.O., C.C., C.R., S.G.).

Fatimah S Dawood (FS)

Centers for Disease Control and Prevention, Atlanta, Georgia (R.H., F.S.D., A.O., C.C., C.R., S.G.).

Alissa O'Halloran (A)

Centers for Disease Control and Prevention, Atlanta, Georgia (R.H., F.S.D., A.O., C.C., C.R., S.G.).

Charisse Cummings (C)

Centers for Disease Control and Prevention, Atlanta, Georgia (R.H., F.S.D., A.O., C.C., C.R., S.G.).

Dawud Ujamaa (D)

Centers for Disease Control and Prevention, Atlanta, Georgia, and General Dynamics Information Technology, Falls Church, Virginia (D.U.).

Pam Daily Kirley (P)

California Emerging Infections Program, Oakland, California (P.D.K.).

Kimberly Yousey-Hindes (K)

Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut (K.Y.).

Emily Fawcett (E)

Emerging Infections Program, Georgia Department of Health, and Veterans Affairs Medical Center, Atlanta, Georgia, and Foundation for Atlanta Veterans Education and Research, Decatur, Georgia (E.F.).

Maya L Monroe (ML)

Maryland Department of Health, Baltimore, Maryland (M.L.M.).

Sue Kim (S)

Michigan Department of Health and Human Services, Lansing, Michigan (S.K.).

Ruth Lynfield (R)

Minnesota Department of Health, St. Paul, Minnesota (R.L.).

Chelsea McMullen (C)

New Mexico Department of Health, Santa Fe, New Mexico (C.M.).

Alison Muse (A)

New York State Department of Health, Albany, New York (A.M.).

Nancy M Bennett (NM)

University of Rochester School of Medicine and Dentistry, Rochester, New York (N.M.B.).

Laurie M Billing (LM)

Ohio Department of Health, Columbus, Ohio (L.M.B.).

Melissa Sutton (M)

Oregon Health Authority, Portland, Oregon (M.S., A.T.).

Ann Thomas (A)

Oregon Health Authority, Portland, Oregon (M.S., A.T.).

H Keipp Talbot (HK)

Vanderbilt University School of Medicine, Nashville, Tennessee (H.K.T., W.S.).

William Schaffner (W)

Vanderbilt University School of Medicine, Nashville, Tennessee (H.K.T., W.S.).

Ilene Risk (I)

Salt Lake County Health Department, Salt Lake City, Utah (I.R.).

Carrie Reed (C)

Centers for Disease Control and Prevention, Atlanta, Georgia (R.H., F.S.D., A.O., C.C., C.R., S.G.).

Shikha Garg (S)

Centers for Disease Control and Prevention, Atlanta, Georgia (R.H., F.S.D., A.O., C.C., C.R., S.G.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH